Author: Josh Barney (Page 11)

A surprise finding from our Wladek Minor should improve the process of drug development and help prevent harmful drug interactions.

Our Golam Mohi, PhD, has identified a promising new treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

Here's an interesting article on how cautious infectious-disease experts are being about COVID-19 this Thanksgiving, nearly three years into the pandemic.

A portable "hydrogel" called Volumatrix could change how we treat traumatic injuries both on the battlefield and off.

A high-tech approach we pioneered to treat essential tremor continued to offer relief over five years, a new study shows.

Minorities with the most common form of lung cancer often face much longer waits to access lifesaving radiation therapy than white patients, a new study shows.